Abstract

Objective To verify the accuracy of the modified technique for internal mammary sentinel lymph node biopsy(IM-SLNB)in breast cancer. Methods In the validation study, the radiotracer was injected with the modified technique, and fluorescence tracer was injected into the peritumoral breast tissue. The radioactive IM-SLN was identified by preoperative lymphoscintigraphy and γ probe. The radioactive IM-SLN received biopsy during operation. The status of the fluorescence tracer was identified by the fluorescence imaging system. Results A total of 162 patients were enrolled from Sep. 2013 to Dec. 2014. IM-SLNB was performed in 110 patients. The radiotracer and the fluorescence tracer were identified in the same IM-SLN in 94 cases, and the concordance rate was 85.5%(Case-base, Spearman coefficient correlation 0.823, P<0.001). Conclusion Different tracers injected into the different sites of the intra-parenchyma can reach the same IM-SLN, proving the accuracy of the modified technique and the hypothesis of IM-SLN lymphatic drainage pattern(IM-SLN receives not only the lymphatic drainage from the primary tumor area but the entire breast parenchyma). Key words: Breast Cancer; Internal Mammary; Sentinel Lymph Node Biopsy; Visualization rate

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call